|
1
|
Mills SEE, Nicolson KP and Smith BH:
Chronic pain: A review of its epidemiology and associated factors
in population-based studies. Br J Anaesth. 123:e273–e283.
2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Cohen SP, Vase L and Hooten WM: Chronic
pain: An update on burden, best practices, and new advances.
Lancet. 397:2082–2097. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Tobin DG, Lockwood MB, Kimmel PL, Dember
LM, Eneanya ND, Jhamb M, Nolin TD, Becker WC and Fischer MJ: HOPE
Consortium (Corporate Author). Opioids for chronic pain management
in patients with dialysis-dependent kidney failure. Nat Rev
Nephrol. 18:113–128. 2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Santoni A, Santoni M and Arcuri E: Chronic
cancer pain: Opioids within tumor microenvironment affect
neuroinflammation, tumor and pain evolution. Cancers (Basel).
14(2253)2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Dong ZB, Wang YJ, Wan WJ, Wu J, Wang BJ,
Zhu HL, Xie M and Liu L: Resveratrol ameliorates
oxaliplatin-induced neuropathic pain via anti-inflammatory effects
in rats. Exp Ther Med. 24(586)2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ji RR, Nackley A, Huh Y, Terrando N and
Maixner W: Neuroinflammation and central sensitization in chronic
and widespread pain. Anesthesiology. 129:343–366. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Linnerbauer M, Wheeler MA and Quintana FJ:
Astrocyte crosstalk in CNS inflammation. Neuron. 108:608–622.
2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Huang Y, Xu W and Zhou R: NLRP3
inflammasome activation and cell death. Cell Mol Immunol.
18:2114–2127. 2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhang YZ, Zhang YL, Huang Q, Huang C,
Jiang ZL, Cai F and Shen JF: AdipoRon alleviates free fatty
acid-induced myocardial cell injury via suppressing Nlrp3
inflammasome activation. Diabetes Metab Syndr Obes. 12:2165–2179.
2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Choudhury SM, Ma X, Zeng Z, Luo Z, Li Y,
Nian X, Ma Y, Shi Z, Song R, Zhu Z, et al: Senecavirus a 3D
interacts with NLRP3 to induce IL-1β production by activating NF-κB
and ion channel signals. Microbiol Spectr.
10(e0209721)2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Chen R, Yin C, Fang J and Liu B: The NLRP3
inflammasome: An emerging therapeutic target for chronic pain. J
Neuroinflammation. 18(84)2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yu S, Zhao G, Han F, Liang W, Jiao Y, Li Z
and Li L: Muscone relieves inflammatory pain by inhibiting
microglial activation-mediated inflammatory response via abrogation
of the NOX4/JAK2-STAT3 pathway and NLRP3 inflammasome. Int
Immunopharmacol. 82(106355)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Khan N, Kuo A, Brockman DA, Cooper MA and
Smith MT: Pharmacological inhibition of the NLRP3 inflammasome as a
potential target for multiple sclerosis induced central neuropathic
pain. Inflammopharmacology. 26:77–86. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Dong X, Fu J, Yin X, Cao S, Li X, Lin L
and Huyiligeqi and Ni J: Emodin: A review of its pharmacology,
toxicity and pharmacokinetics. Phytother Res. 30:1207–1218.
2016.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Zhang X, Li J and Guan L: Emodin reduces
inflammatory and nociceptive responses in different pain-and
inflammation-induced mouse models. Comb Chem High Throughput
Screen. 26:989–1000. 2023.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Gao Y, Liu H, Deng L, Zhu G, Xu C, Li G,
Liu S, Xie J, Liu J, Kong F, et al: Effect of emodin on neuropathic
pain transmission mediated by P2X2/3 receptor of primary sensory
neurons. Brain Res Bull. 84:406–413. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Sun T, Wang J, Li X, Li YJ, Feng D, Shi
WL, Zhao MG, Wang JB and Wu YM: Gastrodin relieved complete
Freund's adjuvant-induced spontaneous pain by inhibiting
inflammatory response. Int Immunopharmacol. 41:66–73.
2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hao M, Tang Q, Wang B, Li Y, Ding J, Li M,
Xie M and Zhu H: Resveratrol suppresses bone cancer pain in rats by
attenuating inflammatory responses through the AMPK/Drp1 signaling.
Acta Biochim Biophys Sin (Shanghai). 52:231–240. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Mao Y, Wang C, Tian X, Huang Y, Zhang Y,
Wu H, Yang S, Xu K, Liu Y, Zhang W, et al: Endoplasmic reticulum
stress contributes to nociception via neuroinflammation in a murine
bone cancer pain model. Anesthesiology. 132:357–372.
2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Shi X, Bai H, Wang J, Wang J, Huang L, He
M, Zheng X, Duan Z, Chen D, Zhang J, et al: Behavioral assessment
of sensory, motor, emotion, and cognition in rodent models of
intracerebral hemorrhage. Front Neurol. 12(667511)2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Seeliger D and de Groot BL: Ligand docking
and binding site analysis with PyMOL and Autodock/Vina. J Comput
Aided Mol Des. 24:417–422. 2010.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhang D, Hu X, Qian L, O'Callaghan JP and
Hong JS: Astrogliosis in CNS pathologies: Is there a role for
microglia? Mol Neurobiol. 41:232–241. 2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Cao DY, Zhang ZH, Li RZ, Shi XK, Xi RY,
Zhang GL, Li F and Wang F: A small molecule inhibitor of caspase-1
inhibits NLRP3 inflammasome activation and pyroptosis to alleviate
gouty inflammation. Immunol Lett. 244:28–39. 2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Prior R, Van Helleputte L, Klingl YE and
Van Den Bosch L: HDAC6 as a potential therapeutic target for
peripheral nerve disorders. Expert Opin Ther Targets. 22:993–1007.
2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Picci C, Wong VSC, Costa CJ, McKinnon MC,
Goldberg DC, Swift M, Alam NM, Prusky GT, Shen S, Kozikowski AP, et
al: HDAC6 inhibition promotes alpha-tubulin acetylation and
ameliorates CMT2A peripheral neuropathy in mice. Exp Neurol.
328(113281)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Krukowski K, Ma J, Golonzhka O, Laumet GO,
Gutti T, van Duzer JH, Mazitschek R, Jarpe MB, Heijnen CJ and
Kavelaars A: HDAC6 inhibition effectively reverses
chemotherapy-induced peripheral neuropathy. Pain. 158:1126–1137.
2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Ma J, Trinh RT, Mahant ID, Peng B,
Matthias P, Heijnen CJ and Kavelaars A: Cell-specific role of
histone deacetylase 6 in chemotherapy-induced mechanical allodynia
and loss of intraepidermal nerve fibers. Pain. 160:2877–2890.
2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhou P, Zhou R, Min Y, An LP, Wang F and
Du QY: Network pharmacology and molecular docking analysis on
pharmacological mechanisms of astragalus membranaceus in the
treatment of gastric ulcer. Evid Based Complement Alternat Med.
2022(9007396)2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Evans LW, Bender A, Burnett L, Godoy L,
Shen Y, Staten D, Zhou T, Angermann JE and Ferguson BS: Emodin and
emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity
and cardiac myocyte hypertrophy. J Nutr Biochem.
79(108339)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Magupalli VG, Negro R, Tian Y, Hauenstein
AV, Di Caprio G, Skillern W, Deng Q, Orning P, Alam HB, Maliga Z,
et al: HDAC6 mediates an aggresome-like mechanism for NLRP3 and
pyrin inflammasome activation. Science.
369(eaas8995)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Xu S, Chen H, Ni H and Dai Q: Targeting
HDAC6 attenuates nicotine-induced macrophage pyroptosis via
NF-κB/NLRP3 pathway. Atherosclerosis. 317:1–9. 2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Cao Z, Gu Z, Lin S, Chen D, Wang J, Zhao
Y, Li Y, Liu T, Li Y, Wang Y, et al: attenuation of NLRP3
inflammasome activation by indirubin-derived PROTAC targeting
HDAC6. ACS Chem Biol. 16:2746–2751. 2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Yan S, Wei X, Jian W, Qin Y, Liu J, Zhu S,
Jiang F, Lou H and Zhang B: Pharmacological inhibition of HDAC6
attenuates NLRP3 inflammatory response and protects dopaminergic
neurons in experimental models of parkinson's disease. Front Aging
Neurosci. 12(78)2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
He J, Zhou Y, Xing J, Wang Q, Zhu H, Zhu Y
and Zou MH: Liver kinase B1 is required for thromboxane
receptor-dependent nuclear factor-κB activation and inflammatory
responses. Arterioscler Thromb Vasc Biol. 33:1297–1305.
2013.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Barter MJ, Butcher A, Wang H, Tsompani D,
Galler M, Rumsby EL, Culley KL, Clark IM and Young DA: HDAC6
regulates NF-κB signalling to control chondrocyte IL-1-induced MMP
and inflammatory gene expression. Sci Rep. 12(6640)2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Yang CJ, Liu YP, Dai HY, Shiue YL, Tsai
CJ, Huang MS and Yeh YT: Nuclear HDAC6 inhibits invasion by
suppressing NF-κB/MMP2 and is inversely correlated with metastasis
of non-small cell lung cancer. Oncotarget. 6:30263–30276.
2015.PubMed/NCBI View Article : Google Scholar
|
